ClinicalTrials.gov
ClinicalTrials.gov Menu

FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00701272
Recruitment Status : Unknown
Verified July 2013 by University Health Network, Toronto.
Recruitment status was:  Enrolling by invitation
First Posted : June 19, 2008
Last Update Posted : July 25, 2013
Sponsor:
Information provided by (Responsible Party):
University Health Network, Toronto